辅助生殖技术 (ART) 市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

辅助生殖技术 (ART) 市场按技术(体外受精 (IVF)、人工授精 (AI-IUI)、冷冻胚胎替换 (FER) 等)、最终用户(医院和生育诊所)进行细分) 和地理

市场快照

 Assisted Reproductive Technology Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: Europe
CAGR: 7.5 %
Assisted Reproductive Technology Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

推动 ART 市场增长的主要因素之一是全球不孕症病例数量的增加。例如,根据美国疾病控制与预防中心(CDC)的估计,在美国,15-44 岁的女性中有 12.1% 的生育能力受损,而同年龄段的已婚女性中有 6.7%不育。反过来,这有望推动对 ART 技术的需求。因此,预计全球不孕症病例的增加将在预测期内推动市场增长。其他因素,如单身女性和同性伴侣数量的增加以及对 IVF 和代孕意识的提高,预计将在预测期内推动市场的增长。

技术进步也是推动市场增长的因素之一。2018 年 1 月,VitriCell SA 宣布关闭 120 万美元。预计这些资金将使公司能够推出基于无菌玻璃化(新细胞冷冻保存技术)的产品。预计这将对未来几年的 ART 市场产生积极影响。

报告范围

辅助生殖技术 (ART) 用于治疗不孕症。体外受精 (IVF) 是最常见和最有效的 ART 类型。然而,多胎妊娠是与 ART 相关的最常见并发症。推动这一市场增长的主要因素是肥胖导致的不孕症病例数量的增加、压力和污染的增加以及全球吸烟者人数的增加。

By Technology
In Vitro-fertilization (IVF)
Artificial Insemination (AI-IUI)
Frozen Embryo Replacement (FER)
Others
By End Users
Hospital
Fertility Clinics
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

体外受精 (IVF) 细分市场预计将在预测年内稳步增长

由于高程序成功率加上不断进步,预计 IVF 将在预测期内增长。越来越多的体外受精治疗鼓励更多的保险提供商承保这些程序。这最终导致了具有竞争力的定价并降低了治疗成本。2016 年,安大略省政府宣布了一项 5000 万美元的生育计划,为 5000 人提供体外受精治疗。

由于生活方式的改变,以及政府为提供更好的报销政策而采取的举措,导致不孕症发病率不断增加,从而推动了市场。预计这将对预测年份的市场增长产生积极影响。

Assisted Reproductive Technology Market Trends

预计欧洲将主导辅助生殖技术市场

欧洲在 ART 市场上占主导地位,预计将在预测期内保持其主导地位,原因是人们对不孕症治疗的认识不断提高、技术进步、政府促进适当 ART 设施的举措以及该地区不孕症病例数量的增加。疾病控制和预防中心 (CDC) 制定了国家公共卫生行动计划,旨在预防、发现和管理世界各地的不孕症病例。大多数欧盟成员国都将不孕症视为一种疾病,其国家政策基金范围从整个治疗到不孕症治疗的某些部分。所有上述因素预计将在预测期内推动该市场的增长。

Assisted Reproductive Technology Market Growth

竞争格局

辅助生殖技术 (ART) 市场的主要参与者包括 - Bloom IVF Centre、CooperSurgical Inc.、Ferring BV、Hamilton Thorne Inc.、FUJIFILM Irvine Scientific, Inc.、Laboratoire CCD、Microm Ltd、Nidacon International AB、OvaScience Inc.、和 Vitrolife。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Number of Infertility Cases

      2. 4.2.2 Rise in Number of Single Women and Same-sex Couples

      3. 4.2.3 Increase in Awareness for IVF and Surrogacy

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost and Socio-ethical Issues

      2. 4.3.2 Changing Government Regulations

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Technology

      1. 5.1.1 In Vitro-fertilization (IVF)

      2. 5.1.2 Artificial Insemination (AI-IUI)

      3. 5.1.3 Frozen Embryo Replacement (FER)

      4. 5.1.4 Others

    2. 5.2 By End Users

      1. 5.2.1 Hospital

      2. 5.2.2 Fertility Clinics

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Bloom IVF Centre

      2. 6.1.2 CooperSurgical Inc.

      3. 6.1.3 Ferring B.V.

      4. 6.1.4 Hamilton Thorne Inc.

      5. 6.1.5 FUJIFILM Irvine Scientific, Inc.

      6. 6.1.6 Laboratoire CCD

      7. 6.1.7 Microm Ltd

      8. 6.1.8 Nidacon International AB

      9. 6.1.9 OvaScience Inc.

      10. 6.1.10 Vitrolife

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Assisted Reproductive Technology (ART) Market market is studied from 2018 - 2026.

The Assisted Reproductive Technology (ART) Market is growing at a CAGR of 7.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

Europe holds highest share in 2021.

CooperSurgical Inc., FUJIFILM Irvine Scientific, Inc., Nidacon International AB, Hamilton Thorne Inc., Ferring B.V. are the major companies operating in Assisted Reproductive Technology (ART) Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!